AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2021
View the entire original 990 at ProPublica ↗
- Organization
- AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
- Tax period
- 2021-06-01 to 2022-05-31
- Filed
- 2023-03-10
- IRS object ID
- 202320699349300622
- Schema version
- 2021v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2023-03-10T16:00:18+00:00 | ReturnTs |
| Tax Period End | 2022-05-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 571157523 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | APRIO LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 111 ROCKVILLE PIKE SUITE 600 | AddressLine1Txt |
| City | ROCKVILLE | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20850 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2021-06-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 237033369 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION FDTN | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | AMER | BusinessNameControlTxt |
| Phone | 3016648612 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY 900 | AddressLine1Txt |
| City | Bethesda | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | STEVEN RUBLOFF | PersonNm |
| Person Title | Chief Executive Officer | PersonTitleTxt |
| Signature | 2023-03-10 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Signing Officer SigningOfficerGrp
Person Full Name PersonFullName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person First | STEVEN | PersonFirstNm |
| Person Last | RUBLOFF | PersonLastNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| SSN | 999009999 | SSN |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | GREGORY M PLOTTS CPA | PreparerPersonNm |
| PTIN | P01255941 | PTIN |
| Phone | 3012316200 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2021 | TaxYr |
| Build TS | 2023-04-26 12:10:37Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ASHP FOUNDATION | BusinessNameLine1Txt |
Principal Ofcr Business Name PrincipalOfcrBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | STEVEN RUBLOFF | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY 900 | AddressLine1Txt |
| City | Bethesda | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $3,511,440 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.ashpfoundation.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1968 | FormationYr |
| Legal Domicile State | MD | LegalDomicileStateCd |
| Activity Or Mission | The mission of the ASHP Foundation is to support ASHP by advancing the professional practice of pharmacists and the pharmacy workforce by funding research and education that improves health outcomes through optimal, safe and effective medication use. | ActivityOrMissionDesc |
| Voting Members Governing Body | 15 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 11 | VotingMembersIndependentCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Total Volunteers | 100 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $2,768,012 | PYContributionsGrantsAmt |
| CY Contributions Grants | $1,421,259 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $1,113,342 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $1,380,758 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,032,723 | PYInvestmentIncomeAmt |
| CY Investment Income | $451,714 | CYInvestmentIncomeAmt |
| CY Other Revenue | $0 | CYOtherRevenueAmt |
| PY Total Revenue | $4,914,077 | PYTotalRevenueAmt |
| CY Total Revenue | $3,253,731 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $431,305 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $384,147 | CYGrantsAndSimilarPaidAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $1,529,410 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $1,650,828 | CYSalariesCompEmpBnftPaidAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $620,979 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $655,666 | PYOtherExpensesAmt |
| CY Other Expenses | $712,310 | CYOtherExpensesAmt |
| PY Total Expenses | $2,616,381 | PYTotalExpensesAmt |
| CY Total Expenses | $2,747,285 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $2,297,696 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $506,446 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $13,642,380 | TotalAssetsBOYAmt |
| Total Assets EOY | $13,385,213 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $691,055 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $941,454 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $12,951,325 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $12,443,759 | NetAssetsOrFundBalancesEOYAmt |
| Mission | OUR MISSION:SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE.OUR VISION:AS THE PHILANTHROPIC ARM OF ASHP, THE FOUNDATION SHARES ASHP'S VISION THAT MEDICATION USE WILL BE OPTIMAL, SAFE, AND EFFECTIVE FOR ALL PEOPLE ALL OF THE TIME. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $924,023 | ExpenseAmt |
| Grant | $131,209 | GrantAmt |
| Revenue | $714,675 | RevenueAmt |
| Desc | Excellence in Pharmacy Practice & Leadership Development: Recognize and promote efforts that foster excellence and growth of health-system pharmacy. ASHP Student Leadership Awards: This program, funded through the David A. Zilz Fund, is administered by the ASHP Pharmacy Student Forum in collaboration with the ASHP Foundation. Nine students who demonstrate high academic achievement, exceptional interest in health-system pharmacy practice, and outstanding leadership skills were recognized. The awardees received a plaque, a $2,000 award and an ASHP drug information library. Each awardee submitted a plan to raise student awareness of the ASHP Practice Advancement Initiative. Awardees will be surveyed to collect information on implementation and outcomes of their plan. Pharmacy Residency Excellence Awards Program: The 2021 Pharmacy Residency Excellence Awards Program was supported by Amgen, Inc and Samson Medical Technologies. This unique award recognizes excellence and leadership in the training and mentoring of pharmacy residents. The Pharmacy Residency Excellence Awards Program recognizes a preceptor, new preceptor and program. The objectives of this program are to: 1) recognize the achievements of residency programs and pharmacists who have demonstrated excellence and leadership in the training of pharmacy residents and 2) widely disseminate the results of these accomplishments to foster innovations in pharmacy resident training. Each awardee will also present an educational webinar on a resident professional development topic that continuing education credits. The webinars are recorded and made available for on-demand access. Literature Awards Program: The ASHP Foundation Literature Awards program recognizes important contributions to the biomedical literature by pharmacists. This program, administered by the ASHP Foundation since 1971, is based on the concept that recognition through awards stimulates research and innovation and fosters improvement in the quality of the evidence. Awardees are recognized at the ASHP Midyear Clinical Meeting. Pain and Palliative Care Traineeship Program: The Pain and Palliative Care Traineeship included access to the ASHP Pain Management Certificate and live case-based webinars, an experiential training component, and a post-traineeship project component, which was supported through participant tuition in FY20. Due to COVID19, experiential training for all participants was postponed. Four pharmacists completed their experiential training in FY22. Two completed it with The University of Maryland, one completed it at The Johns Hopkins Hospitals and one completed it at The University of Iowa Hospitals and Clinics. Pharmacy Residency Expansion Program: In FY22, the ASHP Foundation, supported by an educational donation from Merck, awarded $75,000 dollars in grants to PGY-1 and PGY-2 pharmacy residency programs to increase the number of available training positions. Pharmacy Student Clinical Skills Competition Program: Lauren Campisi & Yumi Oh, Auburn University Harrison School of Pharmacy competed in a virtual competition for the 2021 ASHP National Clinical Skills CompetitionSM, and were awarded in December 2021, during the ASHP Midyear Clinical Meeting (virtual). The Foundation has sponsored the Pharmacy Student Clinical Skills Competition (CSC) at the ASHP Midyear Clinical Meeting 16 years. Teams who won preliminary competitions at their local pharmacy school participated in the competition. During the CSC, students demonstrate their skills by assessing patient information and current therapy, identifying and prioritizing drug therapy problems, identifying treatment goals, and recommending a pharmacist care plan. Medication Safety Scholars Program: ASHP Foundation in partnership with Emily Jerry Foundation and the ASHP Student Forum selected participants for the Medication Safety Scholars program. The program is a distance impact program structured to support five P2 and P3 Doctor of Pharmacy students, paired with one group coach, to enhance their knowledge and skills in medication safety. Thirty applications were received and reviewed by volunteers from the ASHP Medication Safety Section Advisory Group. Visiting Leaders Program (VLP): The Visiting Leaders program, with support from the David A. Zilz Leaders for the Future Fund, had another successful year. Nine leaders were involved in 25 residency visits, reaching residents, in FY22. Due to COVID-19, there were a mix of onsite and virtual visits. Pharmacy Leadership Academy (PLA): The PLA, supported in part by a grant from Apexis, is an online education program designed to provide comprehensive leadership education to pharmacists and pharmacy technicians. The PLA class in FY22 consisted of 116 participants, who also remitted tuition and were enrolled in the program from July 2021 - June 2022. The number of graduates from this class brings the total number of PLA graduates to 1060 pharmacists. Student Leadership Development Workshop: The 3-hour Leadership Development Workshop for pharmacy students is conducted annually at the ASHP Summer Meetings. State affiliates have taken advantage of the program to engage students at their annual meetings. No workshops were scheduled in FY22. William A. Zellmer Leadership Lecture: Where Practice Meets Policy: This annual luncheon-lecture event, hosted by ASHP in partnership with the ASHP Foundation, is designed to honor the distinguished 40-year ASHP career of William A. Zellmer and is supported by donors to the ASHP Foundation's William Zellmer Fund. Rita Shane was awarded in a virtual ceremony in October 2021, so no travel expenses were incurred or remitted in FY22. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $753,473 | ExpenseAmt |
| Grant | $252,937 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | Innovative Research: Support health services research that foster innovation in pharmacy practice, which promotes the optimal, safe and effective use of medication. Pharmacy Practice Advancement Demonstration Grant (PAI): This grant previously awarded funding up to $75,000 split into three (3) separate payments for demonstration projects related to advancing pharmacy practice and improving outcomes. The grant period for this program is 24 months with the possibility for grantees to request an extension up to one year. Tracking progress reports and final grant payments of previous year's recipients took place in FY22. American Foundation for Pharmaceutical Education (AFPE) Pre-Doctoral Fellowship The ASHP Foundation provided annual funding of $10,000 for the AFPE Pre-Doctoral Fellowship program. Radio Frequency Identification (RFID) Initiative: In alignment with the ASHP Innovation Center and through support from Fresenius Kabi, the ASHP Foundation released the RFID research report, which delved into practice gaps, opportunities and challenges for expanding RFID technology in healthcare. A live webinar to discuss the report was conducted by advisory committee members in Spring 2022 and recorded for on-demand access. An RFID demonstration grant was launched in FY22 - no grantees were recommended for funding from the external review process. Sponsor was notified that no grantees were going to be awarded and approved reopening the program application cycle in FY23. Patient Medication Education: In collaboration with phactMI, the Foundation conducted a survey of ASHP members to understand the role, systems and processes, resource needs related to medication education to optimize patient care and outcomes. PhactMI conducted a survey to the public to understand patient education needs and preferences. Results were highlighted in a 2021 ASHP Midyear educational session. A manuscript of all results is still in development. Pharmacy Leadership Scholars: The ASHP Foundation launched a new research grant program with corporate support from Chiesi. The Pharmacy Leadership Scholars program is a research grant program providing funding for projects focused on DEI conducted by early-stage pharmacists. In addition to providing up to $10,000 in grant funding per recipient, the program's goal is to enhance the leadership and research skills of recipients and to provide a network of pharmacists positioned to lead for equity. The selected participants participated in an online impact collaborative consisting of four education modules with a focus on leadership development and DEI. Fifteen proposals were received and advanced for review by an external panel in FY21 and five grants were awarded in FY22. Collaborative Care Grant for Nurses and Pharmacists: Created in partnership by the ASHP Foundation and the American Nurses Foundation, this grant program aims to stimulate patient-centered interprofessional health services research that demonstrates meaningful outcomes. The application launched in FY21 in order to select recipients of research grant funding up to $75,000. Fifteen proposals were received and advanced for review by an external pane and one research team was awarded in FY22. Biosimilars Project: In collaboration with ASHP, the Foundation initiated a research project to explore the opportunities and barriers related to implementing biosimilars in practice. Amgen sponsored the project providing $126,800 to the Foundation, of which $58,800 was budgeted for the research and report to be conducted by the Foundation and $68,000 was budgeted for the dissemination activities to be done by ASHP under the Advantage brand. The Foundation convened an advisory panel of experts, including pharmacists, a physician and payer representation and engaged an interprofessional research panel in virtual qualitative research using the Canvas system. The work of the virtual research panel was completed in FY22 and the advisory panel began creating the report of the findings that was completed in summer, FY23. MUE Project: Development of a medication-use evaluation (MUE) template for andexanet alfa in the reversal of anticoagulation with factor Xa inhibitors: The Foundation initiated a project to create an MUE template for andexanet. The project was funded by Alexion for $95,900. The Foundation engaged a contractor and a medical writer and then convened content matter experts to develop the MUE template using the newly published AJHP MUE guidelines. The deliverables of the project included: the MUE template with implementation strategies and a manuscript to be submitted to AJHP for first right of refusal. Work on the deliverables was not completed in FY22 and continued into FY23, as planned. Specialty Pharmacy Grant: Planning for a new grant to be administered by the Foundation in close consultation with the ASHP Section of Specialty Pharmacy Practitioners was initiated with a survey to registrants of the ASHP Specialty Pharmacy Conference held virtually, July 14-16 2021. Results and input from ASHP and other key stakeholders led to the creation of a grant program focused on specialty pharmacy services for patients being treated for rheumatoid arthritis. The program was designed to be a grant plus cohort engagement with elevated visibility for the grantees to present their results at an ASHP national meeting. Funding for the grant program was ear-marked from excess funds raised by the Foundation to support the ASHP Specialty Pharmacy Summit held in FY21. The grant program was approved the Foundation Board of Directors and opened for submissions January - March, 2021. Five grantees were approved for funding of $5,000 each, in May, 2022. Pharmacy Resident Practice-Based Research Grant Program: This grant program is funded through the ASHP member dues contribution to the Foundation. A six-member external peer review panel recommended awarding 8 grants up to $5,000. One grant was declined because IRB could not be received in time. Funding is distributed upon receipt of IRB-approval, resulting in distribution of grant funds for only 7 recipients in FY22. New Practitioner Pharmacist Leadership Development Research Grant Program: Funded through the Marianne F. Ivey Leadership Development Fund, awards New Practitioner Pharmacists to support research on leadership competency development or to create education, resources and tools to support leadership development. Grant recipients were selected in FY21 for grants up to $5,000 each. Funding is distributed upon receipt of IRB-approval, resulting in distribution of grant funds in FY21 and FY22. Grantees also participated in a virtual Impact Collaborative, consisting of modules that provide educational content and the opportunity to discuss the progress of their projects. The 2021-2022 application cycle was not opened in FY22. Optimizing Technology Solutions Innovation Grant: Seventeen full applications were reviewed by an external panel in order to distribute funding to grantees in FY22. Created in partnership with the ASHP Innovation Center and supported by a generous donation from Omnicell to the ASHP Foundation, each grantee was awarded up to $30,000. Research Advisory Council: In FY22, ASHP Foundation Board of Directors reappointed five members to the Research Advisory Council (RAC) and appointed to seven new members following an open call. The RAC convened in-person in April and virtually throughout the year to review and update the research agenda framework of Core Principles and Priority Research Areas that align with the Foundation's mission and ASHP's major priorities and are at the forefront of the national healthcare agenda. In addition they identified and prioritized ideas to raise awareness of researcher careers and support researcher development. New activities were planned for FY23. Pharmacy Forecast Report 2022: The 2022 Pharmacy Forecast Report was supported by a grant from Omnicell, Inc., to the ASHP Foundation's David A. Zilz Leaders for the Future Fund and was published in AJHP in the January 15, 2022 issue. The distribution of the Forecast Report in AJHP ensured that it was made available to all 60,000 ASHP members. It was published electronically in December 2021 and previewed during an educational session at the 2021 ASHP Midyear Clinical Meeting. The report generated authoritative, actionable strategic recommendations to enhance the effectiveness of leaders in hospital and health-system pharmacy. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $0 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $641,083 | RevenueAmt |
| Desc | THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $1,677,496 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (true) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | false | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | false | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | false | ForeignActivitiesInd |
| More Than5000 K To Org | false | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (true) | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (true) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 72 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 0 | EmployeeCnt |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 15 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 11 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | false | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | false | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Tracy Yaklyvich | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 3016648696 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY SUITE 900 | AddressLine1Txt |
| City | Bethesda | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (18 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| Christene Jolowsky | ||||||||
| Treasurer | 1.0 | 4.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| John T Tighe III | ||||||||
| Chair | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| Kelly M Smith | ||||||||
| Vice Chair | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| Paul W Abramowitz | ||||||||
| President | 3.0 | 40.0 | Yes (X) | Yes (X) | $0 | $1,053,996 | $61,893 | |
| Steven A Rubloff | ||||||||
| Secretary and CEO | 40.0 | 0.0 | Yes (X) | Yes (X) | $367,116 | $0 | $69,787 | |
| Chris Hatwig | ||||||||
| Director At Large | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Ellen Wetterling | ||||||||
| Director At Large | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Janet Mighty | ||||||||
| Director At Large | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Ken Perez | ||||||||
| Director At Large | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Linda Tyler | ||||||||
| ASHP President | 1.0 | 5.0 | Yes (X) | $0 | $10,000 | $0 | ||
| Lindsey Thomas | ||||||||
| Director At Large | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Roger Anderson | ||||||||
| Director At Large | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Scott M Samson | ||||||||
| Director At Large | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Thomas J Johnson | ||||||||
| ASHP Immediate Past President | 1.0 | 0.0 | Yes (X) | $0 | $10,000 | $0 | ||
| Thomas J Rice | ||||||||
| Director At Large | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | ||
| Barbara Nussbaum | ||||||||
| VP, Research and Education | 40.0 | 0.0 | $191,947 | $0 | $57,796 | Yes (X) | ||
| Martha Crews | ||||||||
| VP, Development | 40.0 | 0.0 | $134,752 | $0 | $41,770 | Yes (X) | ||
| Stephanie Brown | ||||||||
| Director, Operations | 40.0 | 0.0 | $125,825 | $0 | $25,420 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $819,640 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $1,073,996 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $256,666 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 4 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
| Cntrct Rcvd Greater Than100 K | 0 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $363,500 | RelatedOrganizationsAmt |
| All Other Contributions | $1,057,759 | AllOtherContributionsAmt |
| Noncash Contributions | $109,448 | NoncashContributionsAmt |
| Total Contributions | $1,421,259 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (4 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | ExclusionExclusionAmt |
|---|---|---|---|---|
| PHARMACY LEADERSHIP ACADEMY | 611430 | $704,675 | $704,675 | |
| CORPORATE PARTNER PROGRAM | 611430 | $641,083 | $641,083 | |
| SPONSORSHIPS | 900099 | $25,000 | $25,000 | |
| PAIN & PALLIATIVE TRAINING | 611430 | $10,000 | $10,000 |
Total Oth Program Service Rev TotalOthProgramServiceRevGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $1,380,758 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $446,440 | TotalRevenueColumnAmt |
| Exclusion | $446,440 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $262,983 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $257,709 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $5,274 | SecuritiesAmt |
| Other | $0 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $5,274 | TotalRevenueColumnAmt |
| Exclusion | $5,274 | ExclusionAmt |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $0 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $0 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,253,731 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,355,758 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $476,714 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $341,647 | TotalAmt |
| Program Services | $341,647 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $42,500 | TotalAmt |
| Program Services | $42,500 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $436,903 | TotalAmt |
| Program Services | $185,398 | ProgramServicesAmt |
| Management And General | $92,324 | ManagementAndGeneralAmt |
| Fundraising | $159,181 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $965,489 | TotalAmt |
| Program Services | $409,700 | ProgramServicesAmt |
| Management And General | $204,023 | ManagementAndGeneralAmt |
| Fundraising | $351,766 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $71,291 | TotalAmt |
| Program Services | $30,252 | ProgramServicesAmt |
| Management And General | $15,064 | ManagementAndGeneralAmt |
| Fundraising | $25,975 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $100,177 | TotalAmt |
| Program Services | $42,510 | ProgramServicesAmt |
| Management And General | $21,169 | ManagementAndGeneralAmt |
| Fundraising | $36,498 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $76,968 | TotalAmt |
| Program Services | $32,661 | ProgramServicesAmt |
| Management And General | $16,264 | ManagementAndGeneralAmt |
| Fundraising | $28,043 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,135 | TotalAmt |
| Management And General | $13,135 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $58,838 | TotalAmt |
| Management And General | $58,838 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $473,405 | TotalAmt |
| Program Services | $464,278 | ProgramServicesAmt |
| Management And General | $255 | ManagementAndGeneralAmt |
| Fundraising | $8,872 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $69,867 | TotalAmt |
| Program Services | $58,619 | ProgramServicesAmt |
| Management And General | $4,347 | ManagementAndGeneralAmt |
| Fundraising | $6,901 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $300 | TotalAmt |
| Management And General | $300 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $37,098 | TotalAmt |
| Program Services | $25,280 | ProgramServicesAmt |
| Management And General | $8,075 | ManagementAndGeneralAmt |
| Fundraising | $3,743 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $42,151 | TotalAmt |
| Program Services | $42,151 | ProgramServicesAmt |
Other Expenses OtherExpensesGrp (2 entries)
| DescDesc | TotalTotalAmt | Management And GeneralManagementAndGeneralAmt | Program ServicesProgramServicesAmt |
|---|---|---|---|
| credit card fees | $15,016 | $15,016 | |
| Honoraria | $2,500 | $2,500 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $0 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,747,285 | TotalAmt |
| Program Services | $1,677,496 | ProgramServicesAmt |
| Management And General | $448,810 | ManagementAndGeneralAmt |
| Fundraising | $620,979 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $264,584 | BOYAmt |
| EOY | $506,045 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $460,822 | BOYAmt |
| EOY | $547,495 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,318,997 | BOYAmt |
| EOY | $1,390,682 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $72,917 | BOYAmt |
| EOY | $74,420 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $68,366 | BOYAmt |
| EOY | $62,661 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $283,347 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $183,665 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $141,833 | BOYAmt |
| EOY | $99,682 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,144,108 | BOYAmt |
| EOY | $10,540,167 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $147,234 | BOYAmt |
| EOY | $115,405 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $23,519 | BOYAmt |
| EOY | $48,656 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $13,642,380 | BOYAmt |
| EOY | $13,385,213 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $180,805 | BOYAmt |
| EOY | $177,452 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $510,250 | BOYAmt |
| EOY | $764,002 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $691,055 | BOYAmt |
| EOY | $941,454 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,192,823 | BOYAmt |
| EOY | $3,083,557 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,758,502 | BOYAmt |
| EOY | $9,360,202 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,951,325 | BOYAmt |
| EOY | $12,443,759 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $13,642,380 | BOYAmt |
| EOY | $13,385,213 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $506,446 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$1,014,012 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consol And Sep Basis Fincl Stmt | Yes (X) | ConsolAndSepBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,088,349 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,768,602 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $928,082 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,768,012 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,421,259 | CurrentTaxYearAmt |
| Total | $8,974,304 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,088,349 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,768,602 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $928,082 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,768,012 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,421,259 | CurrentTaxYearAmt |
| Total | $8,974,304 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $4,380,763 | SubstantialContributorsTotAmt |
| Public Support Total170 | $4,593,541 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $315,175 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $406,338 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $303,024 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $338,642 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $446,440 | CurrentTaxYearAmt |
| Total | $1,809,619 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $0 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $0 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $0 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $0 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $0 | CurrentTaxYearAmt |
| Total | $0 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $10,783,923 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $4,778,592 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.4260 | PublicSupportCY170Pct |
| Public Support PY170 | 0.4449 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,675,259 | BeginningYearBalanceAmt |
| Contributions | $23,200 | ContributionsAmt |
| Investment Earnings Or Losses | -$221,586 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $192,096 | OtherExpendituresAmt |
| End Year Balance | $7,284,777 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,731,177 | BeginningYearBalanceAmt |
| Contributions | $2,650 | ContributionsAmt |
| Investment Earnings Or Losses | $2,218,348 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $1,276,916 | OtherExpendituresAmt |
| End Year Balance | $7,675,259 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,808,429 | BeginningYearBalanceAmt |
| Contributions | $1,300 | ContributionsAmt |
| Investment Earnings Or Losses | $106,680 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $185,232 | OtherExpendituresAmt |
| End Year Balance | $6,731,177 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,838,821 | BeginningYearBalanceAmt |
| Contributions | $1,480 | ContributionsAmt |
| Investment Earnings Or Losses | $93,478 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $125,350 | OtherExpendituresAmt |
| End Year Balance | $6,808,429 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,732,965 | BeginningYearBalanceAmt |
| Contributions | $6,019 | ContributionsAmt |
| Investment Earnings Or Losses | $423,554 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $323,717 | OtherExpendituresAmt |
| End Year Balance | $6,838,821 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.0691 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.7022 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.2287 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $83,984 | OtherCostOrOtherBasisAmt |
| Depreciation | $83,984 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $199,363 | OtherCostOrOtherBasisAmt |
| Depreciation | $99,681 | DepreciationAmt |
| Book Value | $99,682 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $99,682 | TotalBookValueLandBuildingsAmt |
| Total Rev Etc Audited Fincl Stmt | $2,458,714 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$1,014,012 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $277,833 | DonatedServicesAndUseFcltsAmt |
| Other Revenue | $0 | OtherRevenueAmt |
| Revenue Not Reported | -$736,179 | RevenueNotReportedAmt |
| Revenue Subtotal | $3,194,893 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $58,838 | InvestmentExpensesNotIncldAmt |
| Other Revenues Not Included | $0 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $58,838 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $3,253,731 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $2,966,280 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $277,833 | DonatedServicesUseFcltsAmt |
| Other Expenses Included | $0 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $277,833 | ExpensesNotReportedAmt |
| Expenses Subtotal | $2,688,447 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $58,838 | InvestmentExpensesNotIncld2Amt |
| Other Expenses Not Included | $0 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $58,838 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $2,747,285 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule D, Part V, Line 4 Intended uses of endowment funds | FormAndLineReferenceDesc |
| Explanation | THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH IS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (13 entries)
| Address Line1USAddress/AddressLine1Txt | Address Line2USAddress/AddressLine2Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION | ||||||||
| 11325 RANDOM HILLS ROAd | SUITE 360-A105 | FAIRFAX | VA | 22030 | 530214882 | 501(C)(3) | $10,000 | THE PURPOSE OF THE GRANT WAS 2021 SPONSORSHIP |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||||||||
| 4500 EAST-WEST HIGHWAY SUITE 900 | SUITE 900 | BETHESDA | MD | 20814 | 520807628 | 501(C)(6) | $15,800 | CLINICAL SKILL COMPETITION GRANT |
| FLORIDA A&M UNIVERSITY | ||||||||
| FOOTE HILYER ADMIN CENTER | 1700 LEE HALL DRIVE ROOM 201 | TALLAHASSEE | FL | 32307 | 590977035 | STATE UNIVERSITY | $25,500 | PRACTICE ADVANCE GRANT ASSISTANT |
| H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC | ||||||||
| 12902 MAGNOLIA DRIVE | TAMPA | FL | 33612 | 592451713 | 501(C)(3) | $23,600 | PRACTICE ADVANCEMENT GRANT & GRANT REFUND | |
| LEHIGH VALLEY HEALTH NETWORK | ||||||||
| 2100 MACK BOULEVARD | ALLENTOWN | PA | 181035622 | 231689692 | 501(C)(3) | $25,000 | RESIDENT EXPANSION GRANT ASSISTANT | |
| NORTHERN CALIFORNIA HEALTH SERVICES & RESEARCH FOUNDATION | ||||||||
| 5150 FAIR OAKS BOULEVARD | 101-285 | CARMICHAEL | CA | 95608 | 215731085 | 501(C)(3) | $10,000 | PHARMACY LEADERSHIP SCHOLARS GRANT |
| STATE OF MISSISSIPPI UNIVERSITY OF MISSISSIPPI MEDICAL CENTER | ||||||||
| 2500 NORTH STATE STREET | JACKSON | MS | 392164505 | 646008520 | 501(C)(3) | $25,000 | RESIDENT EXPANSION GRANT ASSISTANT | |
| TEXAS SOUTHERN UNIVERSITY | ||||||||
| 3100 CLEBURNE STREET | HOUSTON | TX | 770044598 | 746001391 | STATE UNIVERSITY | $10,000 | PHARMACY LEADERSHIP SCHOLARS GRANT | |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | ||||||||
| UC DAVIS MEDICAL CENTER | 4800 2ND AVENUE 3010 | SACRAMENTO | CA | 95817 | 946036494 | GOVERNMENT | $35,000 | Resident Expansion Grant & Pharmacy Leadership Scholars Grant |
| UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC | ||||||||
| 310 EAST CAMPUS ROAD | ATHENS | GA | 30602 | 581353149 | 501(C)(3) | $30,000 | Optimizing Technology Innovation Grant | |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||
| PO BOX 402420 | ATLANTA | GA | 303842420 | 566001393 | 501(C)(3) | $22,479 | New Practitioner Grant, Pharmacy Leadership Scholars Grant & 2021 Residency Grant | |
| UNIVERSITY OF PITTSBURGH | ||||||||
| 500 ROSS STREET | SUITE 154-0455 | PITTSBURGH | PA | 152620001 | 250965591 | 501(C)(3) | $47,339 | American Nurses Foundation Grant & Pharmacy Leadership Scholars Grant |
| UNIVERSITY OF PUERTO RICO - MED SCIENCES | ||||||||
| PO BOX 365067 | SAN JUAN | PR | 009365067 | 660433762 | STATE INSTITUTION | $30,000 | Optimizing Technology Innovation Grant | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 12 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)
| Grant TypeGrantTypeTxt | RecipientRecipientCnt | Cash GrantCashGrantAmt |
|---|---|---|
| Literature Awards | 5 | $18,500 |
| Student Leadership Awards | 12 | $24,000 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds. | FormAndLineReferenceDesc |
| Explanation | THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED, WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Written Employment Contract | Yes (X) | WrittenEmploymentContractInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | Yes (true) | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | Yes (true) | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steven A Rubloff | ||||||||||||||
| Secretary and CEO | $339,794 | $0 | $25,000 | $0 | $2,322 | $0 | $28,700 | $0 | $41,087 | $0 | $436,903 | $0 | $0 | $0 |
| Paul W Abramowitz | ||||||||||||||
| President | $0 | $852,052 | $0 | $177,500 | $0 | $24,444 | $0 | $28,700 | $0 | $33,193 | $0 | $1,115,889 | $0 | $0 |
| Barbara Nussbaum | ||||||||||||||
| VP, Research and Education | $181,922 | $0 | $8,254 | $0 | $1,771 | $0 | $19,416 | $0 | $38,380 | $0 | $249,743 | $0 | $0 | $0 |
| Martha Crews | ||||||||||||||
| VP, Development | $128,314 | $0 | $5,801 | $0 | $637 | $0 | $9,714 | $0 | $32,056 | $0 | $176,522 | $0 | $0 | $0 |
| Stephanie Brown | ||||||||||||||
| Director, Operations | $120,462 | $0 | $5,152 | $0 | $211 | $0 | $12,101 | $0 | $13,319 | $0 | $151,245 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Schedule J, Part I, Line 6a Compensation contingent on net earnings of the organization | PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS. |
| Schedule J, Part I, Line 6b Compensation contingent on net earnings of a related organization | PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF, Chief Executive Officer, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS. |
| Schedule J, Part I, Line 7 Non-fixed payments | ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES. |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 1873 | ContributionCnt |
| Noncash Contributions Rpt F990 | $109,448 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | Market value | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | false | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule M, Part I Explanations of reporting method for number of contributions | FormAndLineReferenceDesc |
| Explanation | Securities - Publicly traded - The number reported in column (b) represents the number of shares received. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (7 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part VI, Line 7a Members or stockholders electing members of governing body | THREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, CEO, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND CEO SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD. |
| Form 990, Part VI, Line 8b Documentation of meetings held by committees of governing body | THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. |
| Form 990, Part VI, Line 11b Review of form 990 by governing body | The Form 990 is reviewed by officers of ASHP and ASHP Foundation and by the Board before it is filed. Each member has the opportunity to review the Form 990. |
| Form 990, Part VI, Line 12c Conflict of interest policy | THE CONFLICT OF INTEREST POLICY WILL BE REVIEWED ANNUALLY AT THE SPRING OR FALL MEETING. |
| Form 990, Part VI, Line 15a Process to establish compensation of top management official | CHIEF EXECUTIVE OFFICER: PURSUANT TO THE BYLAWS, THE BOARD OF DIRECTORS HAS THE RESPONSIBILITY FOR THE SELECTION AND HIRING OF THE CEO OF THE ORGANIZATION. ELEVEN MEMBERS OF THE BOARD ARE CONSIDERED INDEPENDENT PERSONS AND RECEIVE NO COMPENSATION FROM THE ORGANIZATION. THE BOARD REVIEWS SALARY SURVEY DATA REPORTS FOR OTHER COMPARABLE EXEMPT ORGANIZATIONS AS WELL AS DATA FOR POSITIONS WHICH HAVE SIMILAR RESPONSIBILITIES. OTHER EMPLOYEES WHO ARE EMPLOYED BY THE ORGANIZATION ARE "EMPLOYEES AT WILL". SALARIES FOR THESE INDIVIDUALS ARE DETERMINED USING RELEVANT COMPARABLE SALARY DATA. PRIOR TO FILLING A VACANT POSITION, A HIRING SUPERVISOR, IN CONJUNCTION WITH THE HUMAN RESOURCES DIVISION, RESEARCHES RELEVANT SALARY RANGES FOR THE POSITION. |
| Form 990, Part VI, Line 19 Required documents available to the public | THE FOUNDATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. |
| Form 990, Part IX, Line 11g Other Fees | CONTRACT SERVICES - Total Expense: 473405, Program Service Expense: 464278, Management and General Expenses: 255, Fundraising Expenses: 8872; |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP) | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4500 EAST-WEST HIGHWAY | AddressLine1Txt |
| Address Line2 | SUITE 900 | AddressLine2Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 520807628 | EIN |
| Primary Activities | TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION | PrimaryActivitiesTxt |
| Legal Domicile State | MD | LegalDomicileStateCd |
| Exempt Code Section | 501(c)(6) | ExemptCodeSectionTxt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | NA | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Controlled Organization | false | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (true) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (true) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (true) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (true) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | Yes (true) | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (6 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| American Society of Health-System Pharmacists | ||
| P | $1,697,763 | Recorded expenses |
| American Society of Health-System Pharmacists | ||
| S | $1,058,363 | Cash |
| American Society of Health-System Pharmacists | ||
| N | $639,400 | Recorded expenses |
| American Society of Health-System Pharmacists | ||
| C | $363,500 | Cash |
| American Society of Health-System Pharmacists | ||
| O | $180,698 | Fair Value |
| American Society of Health-System Pharmacists | ||
| B | $15,800 | Cash |
Comments